In melanoma cells, overexpression of SSX2 was shown to induce instability of pericentromeric heterochromatin in S-phase, and in breast cancer cells, SSX2 overexpression induced a senescence response in a S-phase dependent manner (17, 27). Here, SSX2 is linked to breast carcinoma.